Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Exp Neurol. 2011 Aug 18;232(2):126–135. doi: 10.1016/j.expneurol.2011.05.025

Table 4.

Effect of ARA290 Treatment on Reversal of Neuronal Pathology in Akita Mouse Prevertebral Sympathetic Ganglia

Experimental Group Neuron Number Degenerating Neuron Frequency
(neurons/ganglion) (%)
Saline Treated Akita (n=6-7) 4435 ± 692b 2.1 ± 0.4a
ARA290 Treated Akita (n=8) 4373 ± 724a 1.5 ± 0.1a
Combined Saline & ARA290 Treated Controls (n=8-10) 8442 ± 729 0.04 ± 0.01
Akita - 4 month Diabetic (starting point for Rx) (n=4) --- 7.0 ± 1.3 (plastic section data)

Values represent the means ± SEM of n mice.

Statistical Comparison:

a

p≤0.001

b

p<0.01 vs. control